Literature DB >> 26234481

External Nasal Neuralgia: A Neuropathic Pain Within the Territory of the External Nasal Nerve.

Héctor García-Moreno1, Ángel Aledo-Serrano1, Jesús Gimeno-Hernández2, María-Luz Cuadrado1,3.   

Abstract

BACKGROUND: Nasal pain is a challenging diagnosis and very little has been reported in the neurological literature. The nose is a sophisticated structure regarding its innervation, which is supplied by the first and second divisions of the trigeminal nerve. Painful cranial neuropathies are an important group in the differential diagnosis, although they have been described only scarcely. Here, we report a case that can conform a non-traumatic external nasal nerve neuralgia. CASE: A 76-year-old woman was referred to our office due to pain in her left nose. She was suffering from daily excruciating attacks, which were strictly limited to the territory supplied by her left external nasal nerve (left ala nasi and apex nasi). She denied previous traumatisms and the ancillary tests did not yield any underlying pathology. An anesthetic blockade of her left external nasal nerve achieved a marked reduction of the number of episodes as well as their intensity.
CONCLUSION: External nasal neuralgia seems a specific neuralgia causing nasal pain. Anesthetic blockades of the external nasal nerve may be a valid treatment for this condition.
© 2015 American Headache Society.

Entities:  

Keywords:  anesthetic blockade; external nasal nerve; external nasal neuralgia; nasal pain; nasociliary neuralgia

Mesh:

Substances:

Year:  2015        PMID: 26234481     DOI: 10.1111/head.12625

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  2 in total

Review 1.  External Nasal Neuralgia: an Update.

Authors:  Hida Nierenburg; Morgane Swift Morris
Journal:  Curr Pain Headache Rep       Date:  2017-09-13

2.  A Case of Post-traumatic Persistent Nasal Pain.

Authors:  Marta Puma; Barbara Petolicchio; Alessandro Viganò; Ilaria Maestrini; Vittorio Di Piero
Journal:  Front Neurol       Date:  2020-02-03       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.